The RNSM announced that it had sold its old factory site for ?8.575 million, which is way above the value shown in the company accounts. It looks as if this will increase the companys Balance Sheet value by approx. 35/40%. The companys Market value (based on the current share price of 42p) is under ?10 million, whilst the Balance Sheet value will be approx. 15/16 million.
This would seem to indicate a seriously undervalued (and cash rich)company.

Ransom(William) & Son PLC
16 January 2007


Acquisition of shares for the William Ransom & Son plc Share Incentive Plan


William Ransom & Son (the 'Company') announces that WR Trustees Company Limited,
a wholly owned subsidiary of the Company, has today acquired a total of 172
shares in the Company on behalf of the William Ransom & Son plc Share Incentive
Plan (the 'Plan') at an average price of 54.0p per share. The Plan is an
employee share scheme open to all employees and directors of the Company. The
Company requires that any dividends payable in respect of shares held within the
Plan be used to buy more shares and for the shares to be purchased, by the
Trustee, within 30 days of the dividend being paid. Following that acquisition
of shares, Robert Howard, Finance Director of the Company is now the beneficial
owner of an additional 34 ordinary shares bringing his total beneficial
ownership to 83,290 shares representing 0.1 % of the Company's issued share
capital and Timothy Dye, Chairman of the Company is now the beneficial owner of
an additional 8 ordinary shares bringing his total beneficial ownership to
975,388 shares representing 1.16 % of the Company's issued share capital.




This information is provided by RNS
The company news service from the London Stock Exchange

LONDON (AFX) - Healthcare company William Ransom & Son PLC said executive chairman Timothy Dye bought 100,000 shares at 40 pence each, lifting his total stakeholding in the company to 1.075 mln shares or about 1.28 pct.
This is a good sign.

Sold by RHPS causing the fall. Well done Mr Bullford, think I'll hold though.

The market seem to like this news.
LONDON (AFX) - William Ransom & Son PLC said it has signed a ten-year deal to market and distribute a branded glucosamine product in the UK, based on Navamedic ASA's Glucomed/Flexove product.

Ransom paid the Norwegian pharmaceutical company 0.6 mln stg and guaranteed minimum purchases for two years, in exchange for exclusive rights to the UK's first licensed pharmaceutical glucosamine, expected to be launched in the second half this year.

Chairman Tim Dye said, 'The prescription market for glucosamine continues to expand rapidly as a result of the product's excellent safety profile compared to other drugs for the treatment of arthritis and other chronic diseases.'

And so it should goal, this licensed product not only provides revenue but will also provide reasurance to GP and patient alike. I just hope its priced competivly to ensure that similar un-licensed products don't push it out of the market. Very good news from Ransom, I hope to see a return sp of 50 at least within the next few weeks.

Preliminary Results look good to me.

Would Foot and Mouth affect this companies exports?

Natural products getting banned perhaps.

Hello brianboru, it is looking like that to me because I can't see any other reason for the recent drop in the price.

Me neither goal, 20% in around a week, tempted to start buying at these prices..

Yes, very tempting.

10% of the the company 'appeared' to change hands this a.m. (8,800,000 shares) at 39.5 - it would appear to be inter broker dealing but even so quite a lot!!

Edit - I dipped my toe in and bought last Thursday - the F&M scare seems to be over.

LONDON (Thomson Financial) - William Ransom & Son PLC said it has formed a multi-channel retail joint venture with MDY Healthcare PLC to sell a range natural healthcare products direct to consumers via internet, mail order and telesales.

The natural healthcare company said the products will be primarily sourced or manufactured by Ransom, while MDY Healthcare will provide up to 3 mln stg to finance the joint venture, as well as management support and project management services.

Ransom said it expects the joint venture company to launch commercial activities in 2008.

The newly created joint venture company will initially be majority-owned by MDY Healthcare, while Ransom will have an option to acquire 100 pct of the joint venture company according to an agreed timetable and valuation process.

Interesting deal, sp seams to slowly regaining lost ground. This has to be one of the safest 10% gainers over 6 months for anyone wanting to take the plunge. Just goes to show how cautious markets remain.

Well look at Ransom now. 20p - Yikes!
- Could this association be the reason?
Oh dear and such a good company (Trading abt 50p) er, until recently. However, MDY has had a chequered path, mostly downwards - remember the hype over their retractable syringes . . . oh dear, oh dear. Bargepoles.
All IMHO, and DYOR there may be other reasons and the "deal" was an attempt to absolve their errors. . . .

Gut feeling tells me they will get out of contract manufacturing before to long and concentrate on there own product ranges the profits in contract work are terrible,witham was not a good move in my opinion they should have stayed at Hitchin!!

DYOR

Mega.....

Nothing goods happened since the move, big disappointment, might well take a loss and move on... Forget how long I've been watching this one eat away at my investment..

8p today! Hope you got out, explosive....
+ Oh dear, who could have seen this drop?.....( & see my post of 8 Nov...). er, not that I think the association fact has anything to do with the bad-water issues, rather that the Move, Eyes off Ball etc. means that this management is FOUND wanting, but to let a pen-pushing Gov Inspector find something. . . . makes you kinda Proud to be British, eh?
Grief, and think I nearly invested at the 50p-mark because of their wide-ranging prospects.....er, (and other Bull that management showers us with).

No Bonus this Xmas ( except for the Directors, naturally: the greater they foul-up the greater their pay), - funny that. + Pity the poor s- who finds the blame at their door!
(for me this reinforces: "Cosmetic Co's, are always No..".)

All praise to the Gov. Inspectors, I say! - otherwise just imagine the state of the stuff our wives and girlfriends spread all over.

I am most suprised it took this long,Witham was always going to be the major problem at RNSM and without that magic piece of paper so that they can start production again it will be a financial drain on the company.
I think that the major individual share holders Wilky and co will not be very happy with Tim Dye at the moment as they all took cash and a vast amount of shares in the various take over deals.

With the shares at a low for many years,they could be a takeover target because they do have some good brand names under there belt but someone could buy the company out strip the brands out and relocate the production to other facilities who have that vital licence.

This is only my opinion,please DYOR

Mega.....

LONDON (Thomson Financial) - William Ransom staged a welcome rally, rebounding 2 pence to 12-1/2, as the Medicine and Healthcare products Regulatory Agency (MHRA) concluded a voluntary recall of all products containing purified water from the company\'s pharmaceutical contract manufacturing facility at Witham, Essex, is no longer required.

Consequently, its Radian, Valderma and Pavacol brands are not subject to recall.

The MHRA is understood to be close to concluding its review of all the other products manufactured using purified water at the facility. It is expected a significant majority of these products will not be subject to recall.

The MHRA will also commit to an early re-inspection of the facility with a view to re-instating the manufacturer\'s licence well within the originally imposed three-month deadline.

Explosive: I bought some of these this morning as I reckon the sp should recover at least to the 20p mark fairly swiftly - only fell off a cliff because of the product recalls, which look as though they'll be sorted.